Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palmitoylethanolamide (PEA) in Bipolar Depression
NCT06229977Phase 2Completed
- Start
- May 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palmitoylethanolamide in bipolar disorder (BD). Started May 2023; status: completed.
02
Drugs
palmitoylethanolamide
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT06229977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06229977.